Ocular involvement in nasal natural killer T-cell lymphoma

Luca Cimino(University of Modena and Reggio Emilia), Luca Cappuccini(Azienda Ospedaliera S.Maria), Maurizio Masetti(Arcispedale Sant'Anna), Fiorella Ilariucci(Azienda Sanitaria Unità Locale di Reggio Emilia), Defen Shen(National Eye Institute), Luciano Masini(Casa di Cura Villa Garda), Chi-Chao Chan(National Eye Institute), Antonio Sartori(Azienda Ospedaliera S.Maria)

International Ophthalmology

April 25, 2008

10.1007/s10792-008-9220-8

Cited by 39

Related Papers

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

|The Lancet|2009|665

Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical Study

|Journal of Clinical Oncology|2007|374

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

|Blood|2012|310

Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy

|Blood|2002|152

<i>Pneumocystis carinii</i> pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres

|British Journal of Haematology|2002|149